10X Genomics
TXG----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: 10X Genomics(TXG) predict that the Revenue is 150.84 M (-2.61%), Beat estimate;the EBIT is -17.05 M (+64.87%), Beat estimate;the EPS is -0.1 (+64.29%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.15B2.61%
0.15B5.37%
+0.00B2.76%
EBITExceed expectations
-0.02B64.87%
-0.04B15.79%
+0.02B49.08%
EPSExceed expectations
-0.164.29%
-0.28983.48%
+0.189867.77%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 6, 2026
Estimate Revenue146.61 M
Estimate EBIT-34.9 M
Estimate EPS-0.2471
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf